Dannex Ayrton Starwin Plc (GHSE:DASPHARMA)

Market Cap	86.46M +168.4%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	84.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Dannex Ayrton Starwin

Dannex Ayrton Starwin Plc engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana. The company offers analgesics, hematinic, anti-tussive, dermatological products, anti-convulsing and anti-asthmatics in forms of tablets, capsules, powders, ointments, and chemicals and disinfectants, as well as liquids, such as syrups and suspensions. It provides its products under Durol, Virol, Samalin, Teeder, Koffex, ORS, Rapinol, Asmadrin and Milk of Magnesia brand names. Dannex Ayrton Starwin Plc was founded in 1964 and is base...

• Industry: Pharmaceutical Preparations
• Founded: 1964
• Employees: 83
• Stock Exchange: Ghana Stock Exchange
• Ticker Symbol: DASPHARMA

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Data Sources Report a data error